Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-4-30
pubmed:abstractText
We investigated the effect of a novel ROCK inhibitor, Y-39983, on neurite regeneration in vitro and axonal regeneration in the crushed cat optic nerve in vivo. To determine the effective dose for neurite regeneration, retinal pieces were cultured with ROCK inhibitors, Y-39983 or Y-27632, a well-characterized ROCK inhibitor, and the number and length of TUJ-1-positive neurites were evaluated. The greatest number of neurites protruded at a dose of 3-10 microM Y-39983 and at a dose of 10-100 microM Y-27632, respectively. The neurite number at maximum effect of Y-39983 was greater than that of Y-27632. No significant difference was observed between values of neurite length with the inhibitors. Based on this finding, we examined the effect of Y-39983 on axonal regeneration in the crushed optic nerve in vivo. Immediately after crushing the left optic nerve, Y-39983 was injected into the vitreous and the crushed site. An injection of 10 microM Y-39983 induced the crushed axons to regenerate and pass over the crush site. In contrast, very few axons passed beyond the crush site in the optic nerve with phosphate-buffered saline injection. The second injection of 10 microM Y-39983 on day 7 doubled the number of regenerated axons, suggesting that new axons may have entered into the optic nerve after day 7 and that a continuous supply of the drug may make more axons to regenerate.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0014-4886
pubmed:author
pubmed:issnType
Print
pubmed:volume
205
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
230-40
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:17359977-Amides, pubmed-meshheading:17359977-Animals, pubmed-meshheading:17359977-Axons, pubmed-meshheading:17359977-Cats, pubmed-meshheading:17359977-Cell Survival, pubmed-meshheading:17359977-Cells, Cultured, pubmed-meshheading:17359977-Enzyme Inhibitors, pubmed-meshheading:17359977-Female, pubmed-meshheading:17359977-Injections, pubmed-meshheading:17359977-Intracellular Signaling Peptides and Proteins, pubmed-meshheading:17359977-Male, pubmed-meshheading:17359977-Nerve Crush, pubmed-meshheading:17359977-Nerve Fibers, pubmed-meshheading:17359977-Nerve Regeneration, pubmed-meshheading:17359977-Neuroglia, pubmed-meshheading:17359977-Optic Nerve, pubmed-meshheading:17359977-Protein-Serine-Threonine Kinases, pubmed-meshheading:17359977-Pyridines, pubmed-meshheading:17359977-Retina, pubmed-meshheading:17359977-Retinal Ganglion Cells, pubmed-meshheading:17359977-Time Factors, pubmed-meshheading:17359977-Vitreous Body, pubmed-meshheading:17359977-rho-Associated Kinases
pubmed:year
2007
pubmed:articleTitle
A novel ROCK inhibitor, Y-39983, promotes regeneration of crushed axons of retinal ganglion cells into the optic nerve of adult cats.
pubmed:affiliation
Department of Ophthalmology, Nagoya University Graduate School of Medicine, Tsuruma-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't